AB-71-NB55_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]-1-methyl-piperidin-4-ol, TNF-alpha Release Inhibitors;p38 MAPK Inhibitors targeting MAPK14 (Novartis, 9819930)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/9819930
Similar Terms
Downloads & Tools

Genes

15 genes differentially expressed following the AB-71-NB55_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
BUD31 BUD31 homolog (S. cerevisiae) 0.828544
PXDNL peroxidasin-like 0.633292
UBC ubiquitin C 0.344965
RPS5 ribosomal protein S5 0.32715
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.216523
PGP phosphoglycolate phosphatase 0.216523
RPS27 ribosomal protein S27 0.215418
MYL12B myosin, light chain 12B, regulatory 0.208268

decreased expression

Symbol Name Standardized Value
ZMIZ2 zinc finger, MIZ-type containing 2 -0.52763
AP1S2 adaptor-related protein complex 1, sigma 2 subunit -0.409656
SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 -0.225525
HDAC8 histone deacetylase 8 -0.211942
LIN9 lin-9 DREAM MuvB core complex component -0.211942
MYO5A myosin VA (heavy chain 12, myoxin) -0.211942
SYNGR3 synaptogyrin 3 -0.208268